Adnan Yilmaz Selected Research

Adnan Yilmaz Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2005
4	Inflammation (Inflammations) 10/2022 - 01/2006
4	Necrosis 08/2021 - 11/2018
4	Edema (Dropsy) 01/2020 - 12/2012
3	Ischemia 08/2021 - 01/2020
2	Abdominal Aortic Aneurysm 10/2022 - 08/2021
2	Lung Injury 10/2022 - 01/2020
2	Reperfusion Injury 10/2022 - 11/2020
2	Hemorrhage 10/2022 - 07/2002
2	Fibrosis (Cirrhosis) 01/2022 - 01/2019
2	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 04/2019
2	Periodontitis 12/2021 - 01/2021
2	Obesity 12/2021 - 05/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2015 - 01/2012
1	Aneurysm (Aneurysms) 10/2022
1	Ototoxicity 03/2021
1	Alveolar Bone Loss 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Pre-Eclampsia (Preeclampsia) 10/2020
1	Vascular System Injuries 05/2020
1	Gestational Diabetes (Gestational Diabetes Mellitus) 05/2020
1	Adenocarcinoma 03/2019
1	Amyloid Plaque 01/2019
1	Lymphadenitis (Adenitis) 06/2018
1	Hypersensitivity (Allergy) 08/2015
1	Pancreatitis 08/2015
1	Pneumonia (Pneumonitis) 11/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 01/2014
1	Lung Diseases (Lung Disease) 10/2013
1	Pleural Effusion (Pleural Effusions) 10/2013
1	Relapsing-Remitting Multiple Sclerosis 08/2013
1	Multiple Sclerosis 08/2013
1	Muscle Weakness 12/2012
1	Hypertrophy 12/2012
1	Muscular Diseases (Myopathy) 12/2012
1	Myocardial Infarction 11/2012
1	Pain (Aches) 11/2012
1	ST Elevation Myocardial Infarction 11/2012
1	Atherosclerosis 11/2012
1	Shock 11/2012

Drug/Important Bio-Agent (IBA)

9	AntioxidantsIBA 12/2021 - 08/2005
4	Caspase 3 (Caspase-3)IBA 08/2021 - 04/2018
3	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 04/2019
3	MelatoninIBA 01/2021 - 10/2008
3	Oxidants (Oxidizing Agents)IBA 11/2018 - 08/2013
2	Glutathione (Reduced Glutathione)IBA 10/2022 - 01/2020
2	Malondialdehyde (Propanedial)IBA 10/2022 - 01/2020
2	Dexmedetomidine FDA Link 10/2022 - 01/2022
2	astaxanthine (astaxanthin)IBA 03/2021 - 04/2018
2	Proteins (Proteins, Gene)FDA Link 05/2020 - 08/2005
2	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2020 - 10/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2020
2	gadodiamide (Omniscan)FDA Link 01/2019 - 11/2018
2	AcidsIBA 01/2019 - 11/2018
2	Rocuronium (Zemuron)FDA LinkGeneric 08/2015 - 12/2012
2	EnzymesIBA 06/2015 - 09/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2008 - 09/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2008 - 09/2006
1	alpha-2 Adrenergic ReceptorsIBA 10/2022
1	ResveratrolIBA 08/2021
1	Protective AgentsIBA 03/2021
1	CytokinesIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Nebivolol FDA Link 11/2020
1	Saline SolutionIBA 11/2020
1	InterleukinsIBA 10/2020
1	Epidermal Growth Factor (EGF)IBA 05/2020
1	Protein Sorting Signals (Signal Peptide)IBA 05/2020
1	Glycerol (Glycerine)FDA LinkGeneric 01/2020
1	TeaIBA 01/2020
1	Amifostine (Ethyol)FDA LinkGeneric 04/2019
1	CurcuminIBA 04/2019
1	ethyl acetateIBA 03/2019
1	Methylnitronitrosoguanidine (MNNG)IBA 03/2019
1	Contrast MediaIBA 06/2018
1	CreatinineIBA 04/2018
1	NitrogenIBA 04/2018
1	Urea (Carbamide)FDA LinkGeneric 04/2018
1	HDL CholesterolIBA 06/2015
1	Gasoline (Diesel Fuel)IBA 11/2014
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	Aryldialkylphosphatase (Paraoxonase)IBA 08/2013
1	arylesteraseIBA 08/2013
1	SugammadexIBA 12/2012
1	omega-Chloroacetophenone (Mace)IBA 11/2012
1	RANK LigandIBA 11/2012

Therapy/Procedure

4	Thoracotomy 01/2008 - 01/2006
3	Sutures (Suture) 12/2021 - 01/2021
2	Radiotherapy 01/2022 - 01/2019
2	Ligation 12/2021 - 01/2021
2	Sternotomy 07/2016 - 01/2006
2	Operative Surgical Procedures 01/2006 - 11/2004
1	Critical Care (Surgical Intensive Care) 10/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 12/2021
1	Anesthesia 08/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2014
1	Percutaneous Coronary Intervention 11/2012